Why Spectrum Pharmaceuticals Rose 19% Today
In response to reporting fourth-quarter earnings, shares of Spectrum Pharmaceuticals (NASDAQ: SPPI), a beaten-down clinical-stage biotech, rose 19% on Friday.
Spectrum doesn't have any revenue yet, so the financial numbers in its "earnings" report aren't really all that meaningful. However, here are a few of the key figures from the quarter:
Image source: Getty Images.
Source Fool.com
